|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-1-1
|
|
pubmed:abstractText |
To assess the effect of etanercept added to prevailing drug therapy in patients with juvenile idiopathic arthritis (JIA) whose disease was refractory to conventional disease-modifying antirheumatic drug (DMARD) treatment, including combinations of different DMARDs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
867-70
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12508784-Adolescent,
pubmed-meshheading:12508784-Antirheumatic Agents,
pubmed-meshheading:12508784-Arthritis, Juvenile Rheumatoid,
pubmed-meshheading:12508784-Child,
pubmed-meshheading:12508784-Child, Preschool,
pubmed-meshheading:12508784-Drug Therapy, Combination,
pubmed-meshheading:12508784-Female,
pubmed-meshheading:12508784-Humans,
pubmed-meshheading:12508784-Immunoglobulin G,
pubmed-meshheading:12508784-Male,
pubmed-meshheading:12508784-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:12508784-Recombinant Fusion Proteins,
pubmed-meshheading:12508784-Retrospective Studies,
pubmed-meshheading:12508784-Treatment Outcome
|
|
pubmed:articleTitle |
Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis.
|
|
pubmed:affiliation |
Rheumatism Foundation Hospital, FIN-18120 Heinola, Finland. jarkko.haapasaari@reuma.fi
|
|
pubmed:publicationType |
Journal Article
|
